Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Rash
ADR ID BADD_A03695
ADR Hierarchy
23      Skin and subcutaneous tissue disorders
23.03      Epidermal and dermal conditions
23.03.13      Rashes, eruptions and exanthems NEC
23.03.13.001      Rash
Description Diseases in which skin eruptions or rashes are a prominent manifestation. Classically, six such diseases were described with similar rashes; they were numbered in the order in which they were reported. Only the fourth (Duke's disease), fifth (ERYTHEMA INFECTIOSUM), and sixth (EXANTHEMA SUBITUM) numeric designations survive as occasional synonyms in current terminology. [MeSH]
MedDRA Code 10037844
MeSH ID D005076; D005076; D005076
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Dry rash face | Dry rash neck | Eruption | Eruption facial | Eruption of limbs | Exanthem | Exanthema | Extensive rash of forearm | Extensive rash of legs | Facial rash | Hand rash | Neck rash | Patchy rash | Rash | Rash (nonspecific) | Rash both legs | Rash face | Rash in the outer ear | Rash NOS | Rash on face | Rash on legs & arms | Rash over arms | Rash trunk & limbs | Skin eruption | Skin rash | Rash aggravated | Periocular rash | Efflorescence | Exanthema facial | Rash trunk | Localised rash | Localized rash | Rash peripheral | Rash recurrent | Palmoplantar rash | Painful rash | Skin Rash | Rash, Skin
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Arylamine N-acetyltransferase 2P11245Not Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02492Deflazacort0.005050%
BADD_D02494Delafloxacin0.000639%
BADD_D02495Duvelisib0.001332%
BADD_D02496Elagolix0.027444%
BADD_D02498Abemaciclib0.007726%
BADD_D02499Fostamatinib0.001089%
BADD_D02500Alpelisib0.045023%
BADD_D02501Sarecycline0.000426%
BADD_D02503Telotristat ethyl--
BADD_D02504Lorlatinib--
BADD_D02505Gilteritinib0.001598%
BADD_D02507Deutetrabenazine--
BADD_D02508Edaravone--
BADD_D02509Brigatinib--
BADD_D02510Rucaparib0.016517%
BADD_D02511Siponimod--
BADD_D02513Pegvaliase0.042722%
BADD_D02514Etelcalcetide--
BADD_D02515Pexidartinib0.001332%
BADD_D02516Plecanatide0.001220%
BADD_D02517Enasidenib--
BADD_D02518Semaglutide0.020344%
BADD_D02520Baloxavir marboxil0.013020%
BADD_D02521Sodium zirconium cyclosilicate0.005831%
BADD_D02522Lithium citrate--
BADD_D02523Hydrocortisone succinate0.008612%
BADD_D02524Ivosidenib0.001598%
BADD_D02526Larotrectinib0.000533%
The 60th Page    First    Pre   60    Total 60 Pages